Clinical laboratory science : journal of the American Society for Medical Technology最新文献

Approximately 60% to 70% of all health care decisions are based on laboratory test results; therefore, it is important to ensure that patient laboratory results are communicated to the physician in a timely fashion. The objective of this study was to assess the delivery of critical laboratory results in outpatient physician offices in Delaware. Contact information for physician offices was obtained using the Highmark. Blue Cross Blue Shield. physician provider directory. A survey was created using a series of questions regarding the procurement and timely communication of critical laboratory results. Of the offices surveyed, 61.4% indicated that they did not utilize a standard operating procedure specifying who is able to receive the critical laboratory test results and how they should be delivered to the physician. These findings indicate that a change may be necessary to improve the way that critical test results are managed by physician offices.

The intent of the Affordable Care Act is to ensure that all Americans have access to quality, affordable healthcare while significantly reducing the cost burden for this country. It is estimated that an additional 32 million individuals will be covered. The Congressional Budget Office (CBO) estimates this legislation will reduce the deficit by $143 billion in the first 10 years (2011-2020) with an additional $1.2 trillion in savings during the subsequent decade. comprehend and change. That is why it has taken so long to pass any legislation related to this issue. We are almost 50 years post-introduction of Medicare and Medicaid and while there has been much dialogue and a number of infamous attempts to tackle the issue, the ACA is the first successful attempt to pass legislation. History will tell if Congress and the President "got it right" but the alternative of doing nothing was also unacceptable. One might predict that some of what has been legislated and already implemented will stand and result in positive change (i.e. the focus on preventive health and wellness) while other aspects will require change - some minor and some major. We are already seeing changes and timelines that are being modified and delayed. This is a topic that will require an ongoing assessment and look-back to see what was done correctly and what needs to be changed.

Successful research outcomes require selection and implementation of the appropriate research design. A realistic sampling plan appropriate for the design is essential. Qualitative or quantitative methodology may be utilized, depending on the research question and goals. Quantitative research may be experimental where there is an intervention, or nonexperimental, if no intervention is included in the design. Causation can only be established with experimental research. Popular types of nonexperimental research include descriptive and survey research. Research findings may be disseminated via presentations, posters, and publications, such as abstracts and manuscripts.

An entire series could be dedicated to the topic of ethics in personalized medicine. Due to the advancements in NGS and genetic testing, personalized medicine is no longer something that will occur in the future, the reality is upon us now. Sequencing an individual's genome can have a substantial impact on the patient's treatment and overall quality of life. However, this can open "Pandora's box" especially if an individual does not want to know the information obtained. In addition, will insurance companies require genetic testing in order to pay for a targeted treatment? If the patient refuses to have the genetic testing, will they have to pay for their treatment out of pocket? In the human interest story presented, the researcher and his team discovered over activity of the FTL3 protein through RNA sequencing which resulted in rapid proliferation of his leukemic cells. He identified a drug marketed for advanced kidney cancer which was a FTL3 inhibitor. However, his insurance company refused to pay for the drug because it was not a known treatment for his condition of ALL. He incurred numerous out of pocket expenses in order to go into remission. Was it unethical for the insurance company to not pay for a treatment that ultimately worked but was not marketed or FDA cleared for his type of leukemia? There are so many questions and concerns when personalized medicine is implemented. Only time will tell the effects next generation sequencing and its role in personalized medicine will have in the future.

A survey to assess the retirement plans of clinical laboratory professionals (CLP) and the factors that would influence those plans was distributed to members of the American Society for Clinical Laboratory Science (ASCLS) in May, 2012. A majority of respondents (65%) between 50-62 years indicated that there was a greater than 50% chance they would be working after age 62. Only 15.8% of the respondents thought that there was a greater than 50% chance that they would be working full time after they retired from their current job. The retirement option selected most often by respondents was part time work. This was true for respondents in all age groups and job functions. The greatest personal influence on retirement plans was concern about health issues. The results indicate that, if employers can provide part time options, older workers may stay in the workforce as long as they are healthy.